In this podcast, Joëlle E. Vergroesen, MSc, discusses the results of her team's study examining how the use of metformin, insulin, and sulfonylurea derivatives may impact the risk of open-angle glaucoma, age-related macular degeneration (AMD), and cataracts among individuals with type 2 diabetes.
